[Disclosure] Samsung Electronics (005930) – Other Major Management Matters (Voluntary Disclosure) / 2024-11-29
[Disclosure] Celltrion (068270) – Submission of Application for Phase 3 Clinical Trial Plan for CT-P44 (Darzalex Biosimilar) in Europe (Part 1) / 2024-11-28